These data implicate glucose metabolism (i.e. SLC2A1) and carbonic anhydrases (i.e. CAIX) as potential biomarkers for the contribution of chronic alcohol consumption to the initial stages of ESCC. The gene discussed is CA9; the disease is esophageal squamous cell carcinoma.